Further validation via dysadherin knockdown (KD) using the most effective siRNA sequence (#3) confirmed CA9 downregulation in SNU-254 cells (rectal cancer) and patient-derived primary cells (Table S3) (Supplementary Fig. 4i–k). The gene discussed is CA9; the disease is rectal cancer.